Canopy's U.S. Hemp Foray Will Attract U.S. Investors, GMP Says

Jan 15 2019, 1:46 PMJan 15 2019, 2:42 PMJanuary 15 2019, 1:46 PMJanuary 15 2019, 2:42 PM

(Bloomberg) -- Canopy’s hemp license in New York State and its plan to build an extraction and manufacturing facility will make it more appealing to investors looking for exposure to the U.S. cannabis market, GMP analyst Martin Landry writes in a note, raising his price target to C$70 from C$50.

Canopy\'s U.S. Hemp Foray Will Attract U.S. Investors\, GMP Says

Canopy's U.S. Hemp Foray Will Attract U.S. Investors, GMP Says